Sera Prognostics Inc SERA
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-15 |
| Shares Out. | 39,160,000 |
| Website | sera.com/ ↗ |
| Phone | 18015050278 |
| Employees | 72 |
| Revenue | $14,000 |
| Gross Profit | -$28,000 |
| Net Income | -$8.4M |
| Free Cash Flow | -$27.6M |
| Total Assets | $93.5M |
| Total Liabilities | $25.9M |
| Equity | $67.6M |
About Sera Prognostics Inc
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Sera Prognostics Inc is a publicly traded company under the ticker symbol SERA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)